Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China · Delayed Price · Currency is CNY

12.41

+0.11 (0.89%)

Jun 12, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Inter-segment elimination	-1.48B	-	-	-	-
Finished drug Business	2.59B	-	-	-	-
Medical device Business	696.25M	-	-	-	-
Other Business	392.76M	-	-	-	-
Active Pharmaceutical Ingredient Sales	1.86B	-	-	-	-
Total	4.07B	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
East China	1.41B	1.33B	1.47B	1.34B	1.20B
East China Growth	5.62%	-8.93%	9.63%	11.03%	0.80%
North China	509.82M	602.76M	557.41M	611.12M	601.98M
North China Growth	-15.42%	8.14%	-8.79%	1.52%	2.11%
Central China South China	765.42M	949.66M	904.26M	758.61M	714.83M
Central China South China Growth	-19.40%	5.02%	19.20%	6.13%	-
Overseas	856.90M	842.20M	694.90M	715.38M	594.66M
Overseas Growth	1.75%	21.20%	-2.86%	20.30%	13.38%
Other Areas	527.75M	429.44M	376.84M	358.00M	351.16M
Other Areas Growth	22.89%	13.96%	5.26%	1.95%	33.51%
Total	4.07B	4.16B	4.00B	3.78B	3.47B
Total Growth	-2.14%	3.99%	5.79%	9.04%	6.40%